Frontida quickly resolves FDA concerns at U.S. plant it bought from Sun Pharma
admin 15th May 2017 Uncategorised 0Just eight months after receiving an FDA warning letter for a U.S. plant that it bought from Sun Pharma, Frontida BioPharm says the agency has given the plant an all-clear. The warning was tied to issues that the FDA uncovered at the finished pharmaceutical plant in Philadelphia before Frontida took over the plant last June.
More: Frontida quickly resolves FDA concerns at U.S. plant it bought from Sun Pharma
Source: fierce